4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Cheng Yin, Xubing Cai, Huijuan Wang, Bingjie Gu, Xiaofan Yang, Rong Zhang, Xiaohui Ji. Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus[J]. The Journal of Biomedical Research, 2018, 32(2): 113-122. DOI: 10.7555/JBR.27.20130046
Citation: Cheng Yin, Xubing Cai, Huijuan Wang, Bingjie Gu, Xiaofan Yang, Rong Zhang, Xiaohui Ji. Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus[J]. The Journal of Biomedical Research, 2018, 32(2): 113-122. DOI: 10.7555/JBR.27.20130046

Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus

More Information
  • Received Date: April 17, 2013
  • Revised Date: June 19, 2013
  • Systemic lupus erythematosus (SLE) is a typical autoimmune disease. Lymphotoxin β receptor (LTβR) signaling plays an important role in autoimmune inflammations. LTβR-Ig fusion protein, LTβR blocking agent, has been used to treat SLE, while its mechanism remains to be fully elucidated. In this study, to investigate the expression of LTβR in the T cells of SLE patients and its roles in the pathogenesis of SLE, we isolated the peripheral blood T cells of SLE patients and normal controls to detect expression of LTβR by flow cytometry and RNA assay. T cells were also stimulated with LIGHT, a ligand of LTβR, and then detected for their LTβR expressions and apoptosis by flow cytometry. Also, their expressions of inflammatory factors and receptors were determined by RNA assay. The results showed that LTβR positive cells were 22.75%6.98% in CD3+ cells of SLE patients, while there were almost no LTβR positive cells in CD3+ cells of normal persons. Moreover, LTβR expression was remarkably higher in CD3, CD4 and CD8 positive T cells of active SLE patients than non/low active patients (all P < 0.05), and positively correlated with increased Ig level, decreased complement level and renal damage. Moreover, the stimulation of SLE T cells with LIGHT promoted higher expression of LTβR, IL-23R and IL-17A, and apoptosis of T cells. In conclusion, we demonstrated a high expression of LTβR in the T cells of SLE patients which may be associated with pathogenesis of SLE.
  • Related Articles

    [1]Yingchao Hu, Yuxian Song, Shuo Yang. Unlocking the novel activation mechanism of human IL-18[J]. The Journal of Biomedical Research, 2024, 38(5): 448-450. DOI: 10.7555/JBR.38.20240154
    [2]Xinyi Dai, Chenxingyue Zhang, Zhiqiang Yin. Therapy outcomes of IL-17 and JAK inhibitors in rosacea: A systematic review[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240107
    [3]Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
    [4]Yanli Wang, Chunmei Hu, Zailiang Wang, Hui Kong, Weiping Xie, Hong Wang. Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients[J]. The Journal of Biomedical Research, 2015, 29(5): 426-428. DOI: 10.7555/JBR.29.20150077
    [5]Xiaofan Yang, Bin Sun, Huijuan Wang, Cheng Yin, Xiaole Wang, Xiaohui Ji. Increased serum IL-10 in lupus patients promotes apoptosis of T cell subsets via the caspase 8 pathway initiated by Fas signaling[J]. The Journal of Biomedical Research, 2015, 29(3): 232-240. DOI: 10.7555/JBR.29.20130037
    [6]Zhida Sun, Rong Zhang, Huijuan Wang, Pengtao Jiang, Jiangquan Zhang, Mingshun Zhang, Lei Gu, Xiaofan Yang, Miaojia Zhang, Xiaohui Ji. Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells[J]. The Journal of Biomedical Research, 2012, 26(6): 456-466. DOI: 10.7555/JBR.26.20120115
    [7]Jian Wang, Lei Xue, Hailong Cao, Fei Cui, Ting Dai, Yijiang Chen. TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation[J]. The Journal of Biomedical Research, 2011, 25(3): 178-184. DOI: 10.1016/S1674-8301(11)60023-7
    [8]Fang Chen, Xiaohua Zhou, Yan Lin, Changwen Jing, Tao Yang, Yong Ji, Yujie Sun, Xiao Han. Resveratrol prevents interleukin-1β-induced dysfunction of pancreatic β-cells[J]. The Journal of Biomedical Research, 2010, 24(5): 381-388. DOI: 10.1016/S1674-8301(10)60051-6
    [9]Chunhua?Zhu, Aihua?Zhang, Songming?Huang, Guixia?Ding, Xiaoqin?Pan, Ronghua?Chen. Interleukin-13?inhibits?cytokines?synthesis?by?blocking?nuclear?factor-κB?and?c-Jun?N-terminal?kinase?in?human?mesangial?cells[J]. The Journal of Biomedical Research, 2010, 24(4): 308-316. DOI: 10.1016/S1674-8301(10)60043-7
    [10]Liying Gao, Liang Sun, Yugui Cui, Zhen Hou, Li Gao, Jing Zhou, Yundong Mao, Suping Han, Jiayin Liu. The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model[J]. The Journal of Biomedical Research, 2010, 24(1): 43-50.
  • Cited by

    Periodical cited type(10)

    1. Pajecki D, Dos Anjos Pinheiro MC, Dantas ACB, et al. Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Treating Obesity in Patients > 65 Years Old: 3-Year Outcomes of a Randomized Trial. J Gastrointest Surg, 2023. DOI:10.1007/s11605-023-05608-w. Online ahead of print
    2. Tu Y, Bao Y, Zhang P. Metabolic surgery in China: present and future. J Mol Cell Biol, 2021, 13(8): 594-609. DOI:10.1093/jmcb/mjab039. Online ahead of print
    3. Santos MPD, Gonçalves JE, Takahashi AAR, et al. Safety and effectiveness of laparoscopic Y-en-Roux gastric bypass surgery in obese elderly patients. Acta Cir Bras, 2020, 35(6): e202000606. DOI:10.1590/s0102-865020200060000006
    4. Shenoy SS, Gilliam A, Mehanna A, et al. Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-en-Y Gastric Bypass in Elderly Bariatric Patients: Safety and Efficacy-a Systematic Review and Meta-analysis. Obes Surg, 2020, 30(11): 4467-4473. DOI:10.1007/s11695-020-04819-3
    5. Parmar C, Mahawar KK, Carr WRJ, et al. Bariatric Surgery in Septuagenarians: a Comparison with <60 Year Olds. Obes Surg, 2017, 27(12): 3165-3169. DOI:10.1007/s11695-017-2739-x
    6. Praveen Raj P, Bhattacharya S, Saravana Kumar S, et al. Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics. Obes Surg, 2017, 27(8): 2113-2119. DOI:10.1007/s11695-017-2615-8
    7. Melissas J, Stavroulakis K, Tzikoulis V, et al. Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program. Obes Surg, 2017, 27(4): 847-855. DOI:10.1007/s11695-016-2395-6
    8. Cottam A, Cottam D, Medlin W, et al. A matched cohort analysis of single anastomosis loop duodenal switch versus Roux-en-Y gastric bypass with 18-month follow-up. Surg Endosc, 2016, 30(9): 3958-64. DOI:10.1007/s00464-015-4707-7
    9. Nassif PA, Malafaia O, Ribas-Filho JM, et al. WHEN AND WHY OPERATE ELDERLY OBESE. Arq Bras Cir Dig, 2015, 28 Suppl 1(Suppl 1): 84-5. DOI:10.1590/S0102-6720201500S100022
    10. Liang H. Metabolic surgery: present and future. J Biomed Res, 2015, 29(2): 91-2. DOI:10.7555/JBR.29.20150033

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3257) PDF downloads (160) Cited by(10)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return